Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Citado por Google
- Similares em SciELO
- Similares em Google
Compartilhar
Revista Colombiana de Cancerología
versão impressa ISSN 0123-9015
Resumo
BUITRAGO-RAMIREZ, Miguel Ricardo; MANTILLA-GAVIRIA, Habib Jussef e CARRENO DUENAS, José Alexander. Thymic tumors: Experience of the National Cancer Institute of Colombia. rev.colomb.cancerol. [online]. 2019, vol.23, n.3, pp.92-98. Epub 26-Out-2019. ISSN 0123-9015. https://doi.org/10.35509/01239015.17.
Objectives:
Thymic tumors have an overall incidence of 0.13 per 100,000 inhabitants, but they represent a significant percentage of mediastinal tumors. There is little literature based on our population, we make a contribution of our experience in the National Cancer Institute.
Methods:
We did a case series study, reviewing the clinical histories of patients with thymic tumors treated at the National Cancer Institute from 2006 to 2017.
Results:
From 2006 to 2017, 31 patients with thymic tumors such as thymoma, thymic hyperplasia, thymic cysts and thymic carcinomas were found, mainly in the female gender and with a median of 62 years of age. 2 patients presented Myasthenia Gravis (MG). 27 patients underwent thymectomy through sternotomy, video-thoracoscopy, thoracostomy among others, obtaining an overall survival greater than 90% at 5 years of follow-up. The stages of Masaoka I, II and III have a better prognosis than type IV regardless of the histological type.
Conclusions:
Thymectomy is the first-line treatment in resectable cases, even when there is a compromise of nearby structures that allow a complete surgical resection. Our results describe behaviors and results similar to those found in the world literature.
Palavras-chave : Thymoma; Thymus Neoplasms; Thymic carcinoma.